{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:44:03Z","timestamp":1759776243700,"version":"3.37.3"},"reference-count":12,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["81260470"],"award-info":[{"award-number":["81260470"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Technology Supporting Program of Jiangxi province","award":["BE2009639"],"award-info":[{"award-number":["BE2009639"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archiv der Pharmazie"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:sec><jats:label\/><jats:p>Dasatinib is an important drug against chronic myeloid leukemia (CML). In this paper, we describe the preparation and anti\u2010CML activity of 2\u2010aminoxazole and 2\u2010aminothiazole dasatinib derivatives. Biological activity was measured by the inhibition of proliferation of human CML K562 cells. The 2\u2010aminoxazole derivatives had similar activities as the 2\u2010aminothiazole derivatives. All newly synthesized compounds demonstrated more potent antiproliferative activity than imatinib. A few compounds (<jats:bold>8b<\/jats:bold>, <jats:bold>8c<\/jats:bold>, <jats:bold>9b<\/jats:bold>) showed nanomolar inhibitory activity, similar to that of dasatinib.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ardp.201600010","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T11:40:05Z","timestamp":1463571605000},"page":"523-531","source":"Crossref","is-referenced-by-count":4,"title":["2\u2010Aminoxazole and 2\u2010Aminothiazole Dasatinib Derivatives as Potent Inhibitors of Chronic Myeloid Leukemia K562 Cells"],"prefix":"10.1002","volume":"349","author":[{"given":"Xing\u2010Xing","family":"Chai","sequence":"first","affiliation":[{"name":"Medical School of Nanchang University Nanchang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi\u2010Ping","family":"Cai","sequence":"additional","affiliation":[{"name":"Medical School of Nanchang University Nanchang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mian\u2010Tian","family":"Yang","sequence":"additional","affiliation":[{"name":"Medical School of Nanchang University Nanchang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Medical School of Nanchang University Nanchang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying\u2010Jun","family":"Fu","sequence":"additional","affiliation":[{"name":"Medical School of Nanchang University Nanchang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan\u2010Zhen","family":"Xiong","sequence":"additional","affiliation":[{"name":"Medical School of Nanchang University Nanchang China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-013-1488-z"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0900653106"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-369041"},{"key":"e_1_2_6_5_1","first-page":"239","volume":"2","author":"Franco F.","year":"2001","journal-title":"Synthesis"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm060727j"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm049486a"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)82331-6"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2010.08.056"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017020"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-008-0351-7"},{"key":"e_1_2_6_12_1","unstructured":"Y. Z.Xiong X. B.He Y. Z.Xiong X. X.Chai C.A. Patent 104163818A 2014."},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00706-014-1403-6"}],"container-title":["Archiv der Pharmazie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fardp.201600010","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ardp.201600010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T09:26:58Z","timestamp":1696584418000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ardp.201600010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1002\/ardp.201600010"],"URL":"https:\/\/doi.org\/10.1002\/ardp.201600010","archive":["Portico"],"relation":{},"ISSN":["0365-6233","1521-4184"],"issn-type":[{"type":"print","value":"0365-6233"},{"type":"electronic","value":"1521-4184"}],"subject":[],"published":{"date-parts":[[2016,5,18]]}}}